Publication:
Treatment following hysteroscopy and endometrial diagnostic biopsy increases chance for live birth in women with chronic endometritis.

cris.virtual.author-orcid0000-0002-1251-950X
cris.virtual.author-orcid0000-0002-6772-6346
cris.virtualsource.author-orcidf873f557-245b-4694-b284-80069b37bc1e
cris.virtualsource.author-orcid33060908-347b-4013-8e1b-b350ce3f9279
cris.virtualsource.author-orcid739973bf-27d2-4e55-932c-d9b5649868a0
cris.virtualsource.author-orcid3360179c-9be9-473b-ac03-a22eb128643e
cris.virtualsource.author-orcidfda93f1d-bf45-4e13-99f4-a32401b1f110
cris.virtualsource.author-orcid1257dd27-72af-4b8a-9060-3f43de13f820
datacite.rightsopen.access
dc.contributor.authorMitter, Vera Ruth
dc.contributor.authorMeier, Sheila
dc.contributor.authorRau, Tilman
dc.contributor.authorGillon, Tessa
dc.contributor.authorMueller, Michael
dc.contributor.authorZwahlen, Marcel
dc.contributor.authorvon Wolff, Michael
dc.contributor.authorKohl Schwartz, Alexandra
dc.date.accessioned2024-10-05T12:19:12Z
dc.date.available2024-10-05T12:19:12Z
dc.date.issued2021-11
dc.description.abstractProblem Repeated implantation failure and recurrent pregnancy loss are associated with chronic endometritis, a persistent endometrial inflammation. Its diagnosis and treatment may increase pregnancy and live birth rates. The aim of this study was to assess the effectiveness of endometrial diagnostic biopsy and subsequent antibiotic treatment in cases of chronic endometritis on reproductive outcomes over a long observation period. Method of Study We conducted a historical cohort study (2014-2018) at our University-based infertility center that included women (n = 108) with repeated implantation failure or recurrent pregnancy loss without known pathologies associated with either condition. Forty-one women underwent a hysteroscopy only (reference group); the remaining 67 women underwent, in addition to the hysteroscopy, an endometrial diagnostic biopsy with immunohistochemically staining for CD138 to detect plasma cells (biopsy group). If one or more plasma cells were detected, the women were treated with doxycycline 100 mg twice a day orally for two weeks. We performed stratified survival analysis (Kaplan-Meier) and Cox regression. Results The biopsy group had higher chances of pregnancy (hazard ratio 2.28; 95% confidence interval 1.23-4.24; P = .009) and of live birth (hazard ratio 2.76; 95% confidence interval 1.30-5.87; P = .008) compared to the reference group. In the sensitivity analysis, repeated implantation failure or recurrent pregnancy loss did not affect the outcome. Conclusions Endometrial diagnostic biopsy followed by antibiotic treatment in case of chronic endometritis in women with repeated implantation failure or recurrent pregnancy loss may increase chances for live birth.
dc.description.numberOfPages11
dc.description.sponsorshipUniversitätsklinik für Frauenheilkunde
dc.description.sponsorshipInstitut für Pathologie, Klinische Pathologie
dc.description.sponsorshipInstitut für Sozial- und Präventivmedizin (ISPM)
dc.identifier.doi10.48350/157390
dc.identifier.pmid34218478
dc.identifier.publisherDOI10.1111/aji.13482
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/56992
dc.language.isoen
dc.publisherBlackwell Publishing
dc.relation.ispartofAmerican journal of reproductive immunology
dc.relation.issn1046-7408
dc.relation.organizationDCD5A442C056E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BECFE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BE2AE17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C3E5E17DE0405C82790C4DE2
dc.subjectEndometrial diagnostic biopsy chronic endometritis plasma cells recurrent pregnancy loss repeated implantation failure time to live birth time to pregnancy
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc300 - Social sciences, sociology & anthropology::360 - Social problems & social services
dc.titleTreatment following hysteroscopy and endometrial diagnostic biopsy increases chance for live birth in women with chronic endometritis.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
dspace.file.typetext
oaire.citation.issue5
oaire.citation.startPagee13482
oaire.citation.volume86
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
oairecerif.author.affiliationInstitut für Pathologie, Klinische Pathologie
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
oairecerif.author.affiliationInstitut für Sozial- und Präventivmedizin (ISPM)
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
oairecerif.author.affiliationUniversitätsklinik für Frauenheilkunde
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.embargoChanged2022-07-05 22:25:05
unibe.date.licenseChanged2023-02-07 07:52:22
unibe.description.ispublishedpub
unibe.eprints.legacyId157390
unibe.journal.abbrevTitleAM J REPROD IMMUNOL
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 2 of 2
Name:
Mitter_AmJReprodImmunol.pdf
Size:
27.68 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
accepted
Name:
Mitter_AmJReprodImmunol_2021.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc/4.0
Content:
published

Collections